Naibec "Confirmation of Anti-Aging Peptide Efficacy in Animals"
Naivek announced on the 13th that it confirmed the anti-aging and regenerative effects on muscle tissue in mouse experiments using its anti-aging peptide. This animal efficacy evaluation is expected to accelerate the clinical advancement of the anti-aging peptide new drug.
Since April 2022, Naivek has built a library of biomarkers specifically expressed in aging stem cells through a national project and identified anti-aging inducing factors. Through this, the company succeeded in developing multilayer nanoparticles for delivering anti-aging factors and differentiation-inducing substances centered on dental boosters. In October last year, Naivek also filed a patent for the related technology, establishing a barrier to entry.
The anti-aging peptide developed by Naivek is characterized by its applicability to various aging-related diseases, including the field of dentistry. The company explained that by establishing aging stem cells and anti-aging stem cells, it can be utilized as a verification system for treatments of aging-related diseases such as brain disorders, muscle loss, osteoporosis, and arthritis.
A Naivek representative stated, “The anti-aging peptide technology can carry various bioactive substances, including anti-aging factors,” and added, “Based on our proprietary drug delivery system, targeting the desired lesion site is possible, enabling platformization.”
He continued, “Unlike existing tissue regeneration technologies, Naivek’s anti-aging peptide reverses intrinsic aging stem cells to induce tissue regeneration, making it a highly versatile tissue regeneration therapeutic,” and added, “Since efficacy has been confirmed in animal experiments, we are hastening preparations for prompt clinical entry.”
Hot Picks Today
Samsung Electronics Union Reaches Tentative Agreement on Bonus Negotiations... "General Strike Postponed"
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Was It You Again?" Elementary Student Involved in Last Week's Vehicle Theft Drives Off Himself This Time
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The company official emphasized, “As we fully enter the super-aged era, we plan to prepare for clinical entry targeting dental diseases and sarcopenia, which have good market potential among numerous elderly diseases,” and added, “In the future, we will expand applications to brain disorders such as dementia, which have higher technical difficulty.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Breaking] Samsung Electronics Labor and Management Officially Sign Tentative Agreement](https://cwcontent.asiae.co.kr/asiaresize/307/2026052022492353201A.jpg)
